A Cross-sectional Survey of Colorectal Cancer Patients in Different Age Groups

Sponsor
Wang Guiyu (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06145230
Collaborator
(none)
430
1
12
35.8

Study Details

Study Description

Brief Summary

This study will help to determine the main clinical symptom differences between patients of different ages, discover the family genetic predisposition of patients of different ages, and obtain the differences in pathological characteristics of patients of different ages, so as to provide help and basis for more accurate and earlier prevention and treatment of colorectal cancer.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Colorectal cancer is one of the common and highly prevalent malignant tumors of the gastrointestinal system. Previous studies have found that there may be some differences in disease characteristics and prognosis of colorectal cancer patients at different ages, such as patients with early-onset colorectal cancer (age <50 years) tend to have a worse prognosis than patients with late-onset colorectal cancer (age ≥50 years). However, existing studies on the characteristics of colorectal cancer patients at different ages are not well studied to answer the differences between these patients and develop targeted diagnostic and treatment strategies. Cross-sectional survey research, which uses survey research to collect data on a characteristic group over a certain period of time and statistically analyzes the data to obtain the characteristics of a certain disease or a certain treatment strategy, is a more mature approach that is particularly suitable for the questions that need to be answered in this study. Investigators found that no similar studies have been registered and conducted by searching the official websites of the China Clinical Research Registry and Clinical Trial, and there is a lack of research data on the Chinese population. Therefore, investigators believe there is an urgent need for a cross-sectional survey to study the symptomatic characteristics, family history, and pathologic features of colorectal cancer patients. This study will help to determine the main clinical symptom differences between patients of different ages, discover the family genetic predisposition of patients of different ages, and obtain the differences in pathological characteristics of patients of different ages, so as to provide help and basis for more accurate and earlier prevention and treatment of colorectal cancer.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    430 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    A Cross-sectional Survey of Symptomatic Characteristics, Family History and Pathologic Features of Colorectal Cancer Patients in Different Age Groups
    Anticipated Study Start Date :
    Dec 1, 2023
    Anticipated Primary Completion Date :
    Oct 1, 2024
    Anticipated Study Completion Date :
    Dec 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    Under 60 group

    Colorectal cancer paitents aged under 60 years old ( do not include 60 years old)

    60-69 group

    Colorectal cancer paitents aged 60-69 years old

    70-79 group

    Colorectal cancer paitents aged 70-79 years old

    80 and over group

    Colorectal cancer paitents aged 80 and over 80 years old

    Outcome Measures

    Primary Outcome Measures

    1. Characteristics of clinical symptoms [2023.12-2024.10]

      Comparison of the characteristics of clinical symptoms in patients of different ages;

    2. Family history [2023.12-2024.10]

      Comparison of the probability of having a family history in patients of different age stages;

    3. Pathological characteristics [2023.12-2024.10]

      Comparison of pathological characteristics of patients at different age stages;

    Secondary Outcome Measures

    1. Risk factors [2024.09-2024.10]

      Analysis of risk factors for stage progression in colorectal cancer patients

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Adults aged 18 years and older with a pathologic diagnosis of colorectal cancer;

    2. Undergoing surgical treatment of the primary lesion;

    3. Voluntary participation of patients.

    Exclusion Criteria:
    1. Do not agree to participate in the survey or withdraw informed consent

    2. Patients did not receive surgical treatment or did not undergo pathologic examination

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 the 2nd Affiliated Hospital of Harbin Medical University Harbin Heilongjiang China 150086

    Sponsors and Collaborators

    • Wang Guiyu

    Investigators

    • Study Chair: Ye Tian, Prof., Second Affiliated Hospital of Harbin Medical University Ethics Committee

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Wang Guiyu, Director of the Department of Colorectal Cancer Surgery, The Second Affiliated Hospital of Harbin Medical University
    ClinicalTrials.gov Identifier:
    NCT06145230
    Other Study ID Numbers:
    • 2ndHarbinMUSUV
    First Posted:
    Nov 24, 2023
    Last Update Posted:
    Nov 24, 2023
    Last Verified:
    Nov 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Wang Guiyu, Director of the Department of Colorectal Cancer Surgery, The Second Affiliated Hospital of Harbin Medical University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 24, 2023